Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
Patient at increased risk for developing a new head and neck squamous cell carcinoma are
invited to take part in this study.
The investigators of this trial will attempt to study the effectiveness of Celecoxib in
preventing cancer in patients who have oral leukoplakia and/or head and neck dysplasia.